Companies To Watch Viking Therapeutics
Viking Therapeutics is a broad-target contender for treating NASH in a pipeline of new drugs for metabolic and endocrine disorders.

San Diego United States Wayne Koberstein Ligand Pharmaceuticals Executive Editor Life Science Leader
Source: lifescienceleader.com